Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network CohortJuan Berenguer, Inmaculada Jarrín, Cristina Díez et al.|Clinical Microbiology and Infection|2021Cited by 50
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practiceInés Suárez‐García, Julia Portilla, Belén Alejos et al.|Journal of Antimicrobial Chemotherapy|2023Cited by 36
Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-upInés Suárez‐García, Félix Gutiérrez, José A. Pérez‐Molina et al.|Journal of Cancer Research and Clinical Oncology|2023Cited by 14
Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in SpainCristina Moreno, Rebeca Izquierdo, Belén Alejos et al.|AIDS Patient Care and STDs|2024Cited by 12
Past and future of HIV infection. A document based on expert opinionEmilio Bouza, E Palomo, Pep Coll et al.|Revista Española de Quimioterapia|2022Cited by 12